
 [
{
"symbol" : "524518",
"exchange" : "BOM",
"id": "2319907",
"t" : "524518",
"e" : "BOM",
"name" : "Krebs Biochemicals And Industries Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=KREB.BO",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524518"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524518"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524518"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "2.28%",
"annual" : "-454.63%",
"ttm" : "-52.06%"
},
{
"title" : "Operating margin",
"recent_quarter" : "9.52%",
"annual" : "-357.95%",
"ttm" : "-33.13%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "-226.62%",
"ttm" : "-12.81%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-13.46%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "-221.51%",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "529",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "+1.65",
"l" : "161.50",
"cp" : "1.03",
"ccol" : "chg",
"op" : "161.50",
"hi" : "163.75",
"lo" : "158.00",
"vo" : "998.00",
"avvo" : "",
"hi52" : "169.45",
"lo52" : "74.15",
"mc" : "2.12B",
"pe" : "",
"fwpe" : "",
"beta" : "",
"eps" : "-10.35",
"dy" : "",
"ldiv" : "",
"shares" : "13.74M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "2319907",
"name" : "Krebs Biochemicals And Industries Ltd",
"t" : "524518",
"e" : "BOM",
"l" : "161.50",
"c" : "+1.65",
"mc" : "2.12B",
"cp" : "1.03",
"ccol" : "chg"
}
,
{
"id" : "8874121",
"name" : "Gujarat Themis Biosyn Ltd",
"t" : "506879",
"e" : "BOM",
"l" : "43.30",
"c" : "-3.05",
"mc" : "625.72M",
"cp" : "-6.58",
"ccol" : "chr"
}
,
{
"id" : "1180250",
"name" : "Kopran Limited (Parent)",
"t" : "KOPRAN",
"e" : "NSE",
"l" : "71.50",
"c" : "+1.50",
"mc" : "3.09B",
"cp" : "2.14",
"ccol" : "chg"
}
,
{
"id" : "8708343",
"name" : "SMS Pharmaceuticals Ltd",
"t" : "SMSPHARMA",
"e" : "NSE",
"l" : "89.35",
"c" : "+0.60",
"mc" : "7.59B",
"cp" : "0.68",
"ccol" : "chg"
}
,
{
"id" : "9025089",
"name" : "RPG Life Sciences Limited",
"t" : "RPGLIFE",
"e" : "NSE",
"l" : "463.00",
"c" : "+10.95",
"mc" : "7.69B",
"cp" : "2.42",
"ccol" : "chg"
}
,
{
"id" : "15490987",
"name" : "TTK Health Care Ltd",
"t" : "TTKHLTCARE",
"e" : "NSE",
"l" : "1,251.00",
"c" : "-10.50",
"mc" : "9.65B",
"cp" : "-0.83",
"ccol" : "chr"
}
,
{
"id" : "451765",
"name" : "J B Chemicals and Pharmaceuticals Ltd",
"t" : "JBCHEPHARM",
"e" : "NSE",
"l" : "315.00",
"c" : "+9.35",
"mc" : "26.32B",
"cp" : "3.06",
"ccol" : "chg"
}
,
{
"id" : "10030871",
"name" : "Unichem Laboratories Limited",
"t" : "UNICHEMLAB",
"e" : "NSE",
"l" : "320.95",
"c" : "-9.05",
"mc" : "29.26B",
"cp" : "-2.74",
"ccol" : "chr"
}
,
{
"id" : "677258",
"name" : "Sun Pharmaceutical Industries Limited",
"t" : "SUNPHARMA",
"e" : "NSE",
"l" : "555.40",
"c" : "-14.25",
"mc" : "1.32T",
"cp" : "-2.50",
"ccol" : "chr"
}
,
{
"id" : "10751448",
"name" : "Albert David Ltd",
"t" : "524075",
"e" : "BOM",
"l" : "370.00",
"c" : "0.00",
"mc" : "2.08B",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "722680",
"name" : "Avon Lifesciences Ltd",
"t" : "531541",
"e" : "BOM",
"l" : "11.65",
"c" : "-0.60",
"mc" : "277.56M",
"cp" : "-4.90",
"ccol" : "chr"
}
]
, "summary" : [{
"address": "Inwinex Towers, Plot No. 130, 4th Floor Road No. 2, Regadichelika Village Banjara Hills, HYDERABAD, 500034, India",
"phone": "+91-40-66808040",
"fax": "+91-40-23540320",
"url": "http:\u002F\u002Fkrebsbiochem.com",
"overview" : "Krebs Biochemicals \u0026 Industries Limited is an India-based company, which develops biotechnology processes for application in medicine, agriculture and industry. The Company undertakes both contract manufacturing for pharmaceutical and multinational companies, and develops products for sale in global markets. The Company manufactures various products, such as Androstenedione for use as Steroid Intermediate, and Lovastatin and Simvastatin for anti-cholesterol. The Company\u0027s products in either pilot or research and development stages include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. The Company\u0027s manufacturing plants, which are located in Nellore and Vizag, are equipped for chemical synthesis, fermentation and enzymatic technologies. The Unit I located at Nellore is a 60-acre site with an effluent treatment plant. The Unit II located at Vizag is a 48-acre site and has a 3.1-megawatt cogeneration power plant."
} ]
, "management" : [
{
"name" : "Avinash Ravi",
"age" : "35",
"title" : "Chief Executive Officer, Chief Operating Officer, Managing Director, Whole Time Director"
}
,
{
"name" : "C. V. R. S. N. Kumar",
"title" : "Chief Financial Officer"
}
,
{
"name" : "Haritha Varanasi",
"title" : "Company Secretary"
}
,
{
"name" : "R. T. Ravi",
"title" : "Non-Executive Chairman of the Board"
}
,
{
"name" : "Satish Khivsara",
"title" : "Additional Independent Director"
}
,
{
"name" : "Raj Kamal Prasad Verma",
"title" : "Additional Independent Director"
}
,
{
"name" : "G. V. L. Prasad",
"age" : "58",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "R. Ch. Satyanarayana",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
